|Bid||0.00 x 1300|
|Ask||0.00 x 1800|
|Day's range||123.34 - 124.99|
|52-week range||87.68 - 132.30|
|Beta (5Y monthly)||0.80|
|PE ratio (TTM)||54.98|
|Earnings date||27 May 2021|
|Forward dividend & yield||2.32 (1.88%)|
|Ex-dividend date||25 Mar 2021|
|1y target est||134.31|
Medtronic's (MDT) first patient-centric digital health platform is expected to provide better outcome for patients undergoing the company's SCS therapy.
United Therapeutics (UTHR) reports mixed first-quarter 2021 results. Higher sales of Orenitram, Unituxin and Tyvaso offset lower sales of Remodulin and Adcirca.
The Zacks Analyst Blog Highlights: Netflix, Medtronic, Stryker, Sysco and EOG Resources